2,064
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Development of phospholipon®90H complex nanocarrier with enhanced oral bioavailability and anti-inflammatory potential of genistein

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2162158 | Received 31 Oct 2022, Accepted 19 Dec 2022, Published online: 01 Jan 2023

References

  • Bhattacharyya S, Majhi S, Saha BP, Mukherjee PK. (2014). Chlorogenic acid-phospholipid complex improve protection against UVA induced oxidative stress. J Photochem Photobiol B 130:1–13.
  • Bildstein L, Dubernet C, Couvreur P. (2011). Prodrug-based intracellular delivery of anticancer agents. Adv Drug Deliv Rev 63:3–23.
  • Botet-Carreras A, Tamames-Tabar C, Salles F, et al. (2021). Improving the genistein oral bioavailability via its formulation into the metal-organic framework MIL-100(Fe). J Mater Chem B 9:2233–9.
  • Braber V, Nunez N, Bohl L, et al. (2018). Soy genistein administered in soluble chitosan microcapsules maintains antioxidant activity and limits intestinal inflammation. J Nutr Biochem 62:50–8.
  • Cai L, Yu R, Hao X, Ding X. (2017). Folate receptor-targeted bioflavonoid genistein-loaded chitosan nanoparticles for enhanced anticancer effect in cervical cancers. Nanoscale Res. Lett 12:1–8.
  • Cai S, Tang ZM, Xiong C, et al. (2022). The anti-inflammatory effects of apigenin and genistein on the rat intestinal epithelial (IEC-6) cells with TNF-α stimulation in response to heat treatment. Can. Res. Food Sci 5:918–26.
  • Chang T, Define L, Alexander T, Kyu T. (2015). In vitro investigation of antioxidant, anti-Inflammatory, and antiplatelet adhesion properties of genistein-modified poly(ether sulfone)/poly(vinylpyrrolidone) hemodialysis membranes. J Biomed Mater Res B Appl Biomater 103:539–47.
  • Constantinides PP, Chaubal MV, Shorr R. (2008). Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv Drug Deliv Rev 60:757–67.
  • Contini C, Schneemilch M, Gaisford S, Quirke N. (2018). Nanoparticle membrane interactions. J. Exp. Nanosci 13:62–81.
  • Dave V, Telange D, Denge R, et al. (2018). Pentaerythritol as an excipient/solid-dispersion carrier for improved solubility and permeability of ursodeoxycholic acid. J Excipients Food Chem 9:80–95.
  • Dev A, Sardoiwala MN, Kushwaha AC, et al. (2021). Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway. Phytomedicine 80:153386.
  • Dhore PW, Dave VS, Saoji SD, et al. (2017). Influence of carrier (polymer) type and drug-carrier ratio in the development of amorphous dispersions for solubility and permeability enhancement of ritonavir. J Excipients Food Chem 8:75–92.
  • Dkhar B, Khongsti K, Thabah D, et al. (2018). Genistein represses PEPCK-C expression in an insulin-independent manner in HepG2 cells and in alloxan-induced diabetic mice. J Cell Biochem 119:1953–1970.
  • Guo Y, Terazzi E, Seemann R, et al. (2016). Direct proof of spontaneous translocation of lipid covering hydrophobic nanoparticles through phospholipids bilayer. Sci Adv 2:1–10.
  • Hussein AM, Attaai AH, Zahran AM. (2022). Genistein anticancer efficacy during induced oral squamous cell carcinoma: an experimental study. J Egypt Natl Canc Inst 34:1–10.
  • Hou Z, Li Y, Huang Y, et al. (2013). Phytosomes loaded with mitomycin C-soyabean phosphatidylcholine complex developed for drug delivery. Mol Pharm 10:90–101.
  • Karthivashan G, Masarudin MJ, Kura AU, et al. (2016). Optimization, formulation, and characterization of multiflavonoids-loaded flavanosome by bulk or sequential technique. Int J Nanomedicine 11:3417–3434.
  • Kidd PM. (2009). Bioavailability and activity of phytosome complexes from botanical polyphenols: The silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 14:226–246.
  • Kobayashi S, Shinohara M, Nagai T, Konishi Y. (2013). Transport mechanisms for soy isoflavones and microbial metabolites dihydrogenistein and dihydrodaidzein across monolayers and membranes. Biosci Biotechnol Biochem 77:2210–2217.
  • Komeil IA, EI-Refaie WM, Gowayed MA, et al. (2021). Oral genistein-loaded phytosomes with enhanced hepatic uptake, residence and improved therapeutic efficacy against hepatocellular carcinoma. Int J Pharm 601:120564.
  • Komeil IA, Abdallah OY, EI-Refaie WM. (2022). Surface modified genistein phytosome for breast cancer treatment: in vitro appraisal, pharmacokinetics, and in vivo anticancer efficacy. Eur J Pharm Sci 179:106297.
  • Küllenberg D, Taylor LA, Schneider M, Massing U. (2012). Health effects of dietary phospholipids. Lipids Health Dis 11:3.
  • Lefevre ME, Olivo R, Vanderhoff JW, Joel DD. (1978). Accumulation of latex in peyer’s patches and its subsequent appearance in villi and mesenteric lymph nodes’. Proc Soc Exp Biol Med 159:298–302.
  • Li J, Wang X, Zhang T, et al. (2015). A review on phospholipids and their main applications in drug delivery systems. Asian J. Pharm. Sci 10:81–98.
  • Li R-z, Ding X-W, Geetha T, et al. (2020). Beneficial effects of genistein on diabetes-induced brain damage in the ob/obmouse model. Drug Des Devel Ther 14:3325–3336.
  • Lopes De Azambuja CR, Dos Santos LG, Rodrigues MR, et al. (2015). Physico-chemical characterization of isolectin-genistein liposomal system: An approach to analyze its in vitro antioxidant potential and effect in glioma cells viability. Chem Phys Lipids 193:24–35.
  • Lu M, Qiu Q, Luo X, et al. (2019). Phyto-phospholipid complexes (phytosomes): a novel strategy to improve the bioavailability of active constituents. Asian J Pharm Sci 14:265–274.
  • Maiti K, Mukherjee K, Murugan V, et al. (2009). Exploring the effect of hesperetin-HSPC complex-a novel drug delivery system on the in vitro release, therapeutic efficacy and pharmacokinetics. AAPS Pharm Sci Tech 10:943–950.
  • Maryana W, Rachmawati H, Mudhakir D. (2016). Formation of Phytosome Containing Silymarin Using Thin Layer-Hydration Technique Aimed for Oral Delivery. Mater Today Proc 3:855–866.
  • Mazumder A, Dwivedi A, Du Preez JL, Du Plessis J. (2016). In vitro wound healing and cytotoxic effects of sinigrin-phytosome complex. Int J Pharm 498:283–293.
  • Murugan V, Mukherjee K, Maiti K, Mukherjee PK. (2009). Enhanced oral bioavailability and antioxidant profile of ellagic acid by phospholipids. J Agric Food Chem 57:4559–4565.
  • Obinu A, Burrai GP, Cavalli R, et al. (2021). Transmucosal solid lipid nanoparticles to improve genistein absorption via intestinal lymphatic transport. Pharmaceutics 13:267.
  • Pandit NT, Patravale VB. (2011). Design and optimization of a novel method for extraction of genistein. Indian J Pharm Sci 73:184–192.
  • Patel NV, Sheth NR, Mohddesi B. (2015). Formulation and evaluation of genistein – a novel isoflavone loaded chitosan and Eudragit® nanoparticles for cancer therapy. Mater Today Proc 2:4477–4482.
  • Pavese JM, Farmer RL, Bergan RC. (2010). Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29:465–482.
  • Perrut M, Jung J, Leboeuf F. (2005). Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: MIcronization of neat particles. Int J Pharm 288:3–10.
  • Renukuntla J, Vadlapudi AD, Patel A, et al. (2013). Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447:75–93.
  • Rothwell JA, Day AJ, Morgan MRA. (2005). Experimental determination of octanol-water partition coefficients of quercetin and related flavonoids. J Agric Food Chem 53:4355–4360.
  • Saha BP, Mukherjee K, Mukherjee PK, et al. (2007). Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330:155–163.
  • Saoji SD, Belgamwar VS, Dharashivkar SS, et al. (2016). The study of the influence of formulation and process variables on the functional attributes of simvastatin–phospholipid complex. J Pharm Innov 11:264–278.
  • Savić R, Luo L, Eisenberg A, Maysinger D. (2003). Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300:615–618.
  • Schoefer L, Mohan R, Braune A, et al. (2002). Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett 208:197–202.
  • Singh D, Rawat MSM, Semalty A, Semalty M. (2013). Chrysophanol–phospholipid complex. J Therm Anal Calorim 111:2069–2077.
  • Spagnuolo C, Russo GL, Orhan IE, et al. (2015). Genistein and cancer: current status, challenges, and future directions. Adv Nutr 6:408–419.
  • Tamura M, Ohnishi-Kameyama M, Nakagawa H, Tsushida T. (2007). Dihydrogenistein-producing bacterium TM-40 isolated from human feces. FSTR 13:129–132.
  • Telange DR, Jain SP, Pethe AM, et al. (2021a). Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid. Int J Biol Macromol 171:288–307.
  • Telange DR, Nirgulkar SB, Umekar MJ, et al. (2019). Enhanced transdermal permeation and anti-inflammatory potential of phospholipids complex-loaded matrix film of umbelliferone: Formulation development, physico-chemical and functional characterization. Eur J Pharm Sci 131:23–38.
  • Telange DR, Patil AT, Pethe AM, et al. (2017). Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential. Eur J Pharm Sci 108:36–49.
  • Telange DR, Patil AT, Pethe AM, et al. (2016). Kaempferol-phospholipid complex: Formulation, and evaluation of improved solubility, in vivo bioavailability, and antioxidant potential of kaempferol. J. Excipients Food Chem 7:89–112.
  • Telange DR, Sohail NK, Hemke AT, et al. (2021b). Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin. Drug Deliv Transl Res 11:1056–1083.
  • Vu Q-L, Fang C-W, Suhail M, Wu P-C. (2021). Enhancement of the topical bioavailability and skin whitening effect of genistein by using microemulsions as drug delivery carriers. Pharmaceuticals 14:1233.
  • Wu JG, Ge J, Zhang YP, et al. (2010). Solubility of genistein in water, methanol, ethanol, propan-2-ol, 1-butanol, and ethyl acetate from (280 to 333) K. J Chem Eng Data 55:5286–5288.
  • Xiao Y, Ho C-T, Chen Y, et al. (2020). Synthesis, characterization, and evaluation of genistein-loaded zein/carboxymethyl chitosan nanoparticles with improved water dispersibility, enhanced antioxidant activity, and controlled release property. Foods 9:1604–1626.
  • Yue PF, Yuan HL, Li XY, et al. (2010). Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex. Int J Pharm 387:139–146.
  • Zafar A, Alruwaili NK, Imam SS, et al. (2021). Formulation of genistein-hp β cyclodextrin-poloxamer 188 ternary inclusion complex: Solubility to cytotoxicity assessment. Pharmaceutics 13:1997.
  • Zhang J, Xiong H, Wang H, et al. (2012). Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 13:534–547.
  • Yang Z, Kulkarni K, Zhu W, Hu M. (2012). Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. Anticancer Agents Med Chem 12:1264–1280.